Cargando…

Apheresis of activated leukocytes with an immobilized polymyxin B filter

Detalles Bibliográficos
Autores principales:	Takeyama, N, Kumagai, T, Harada, M, Kajita, Y, Miki, Y, Kanou, H, Inoue, Y, Nakagawa, T, Noguchi, H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934210/ http://dx.doi.org/10.1186/cc8642

Ejemplares similares

Beneficial effects of the heme oxygenase-1/carbon monoxide system
por: Takeyama, N, et al.
Publicado: (2009)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Oxygen metabolism as an indicator in criteria for hemoperfusion using a polymyxin-B immobilized column introduction
por: Kushi, H, et al.
Publicado: (2005)

Removing endocannabinoids and reducing oxidative stress with polymyxin-B-immobilized fibers in patients with septic shock
por: Kase, Y, et al.
Publicado: (2007)

Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Hemoperfusion with an immobilized polymyxin B fiber column improves gastric mucosal pH with sepsis patients
por: Kushi, H, et al.
Publicado: (2006)

Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2006)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Early introduction of hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
por: Kushi, H, et al.
Publicado: (2005)

Clinical efficacy of long-term performance with polymyxin-B immobilized fiber treatment for septic shock
por: Matumoto, N, et al.
Publicado: (2008)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

Polymyxin B-immobilized fiber hemoperfusion therapy improves sepsis-related immunosuppression
por: Kimura, A, et al.
Publicado: (2014)

More effective use of polymyxin-B hemoperfusion for nonoperation cases
por: Yahata, M, et al.
Publicado: (2014)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Relationship between the use of polymyxin B-immobilized fiber for hemofiltration and some laboratory parameters (endocannabinoids, high mobility group box-1 protein and oxidative stress) in severe pneumonia patients
por: Mashiko, K, et al.
Publicado: (2008)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Mechanism and effectiveness of polymyxin B-immobilized fiber columns for removing mediators (HMBG-1, 2-arachidonoyl glycerol, anandamide, PAI-1, protein C and IL-6) in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2007)

White blood cell counts have an impact on septic patient outcome followed by polymyxin-b immobilized fiber with direct hemoperfusion
por: Tanaka, H, et al.
Publicado: (2015)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Polymyxin B-direct hemoperfusion therapy contributes to oxygen delivery in septic patients
por: Yaguchi, A, et al.
Publicado: (2012)

Catecholamine index is a simple and useful marker for bacteremic patients treated by polymyxin B hemoperfusion therapy
por: Isa, Y, et al.
Publicado: (2011)

High mobility group box 1 levels in septic disseminated intravascular coagulation patients undergoing Polymixin-B immobilized fiber-direct hemoperfusion
por: Ishibe, Y, et al.
Publicado: (2012)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

Polymyxin B-direct hemoperfusion therapy improves mean arterial pressure in septic shock
por: Yokota, Mari, et al.
Publicado: (2013)

Polymyxin B-direct hemoperfusion therapy could contribute to hemodynamics and outcomes in emergency surgical patients
por: Yokota, M, et al.
Publicado: (2012)

The effect of polymixin B immobilized on fibers and continuous veno-venous hemodiafiltration on tetrahydrobiopterine and NO metabolites in septic patients
por: Kakihana, Y, et al.
Publicado: (2006)

Lipopolysaccharide is required for leukocyte adhesion to Toraymyxin(® )filters used in the treatment of sepsis
por: Martin, EL, et al.
Publicado: (2010)

Leukocyte Apheresis in the Management of Ulcerative Colitis
por: Helmy, Ahmed, et al.
Publicado: (2009)

Rat polymyxin b hemoperfusion model: preventive effect on renal tubular cell death in a rat cecal ligation and puncture model
por: Masuda, T, et al.
Publicado: (2015)

Efficacy of endotoxin absorption therapy on sepsis by polymyxin B-attached fibers
por: Atagi, K
Publicado: (2011)

Modulation of inflammatory response related to severe peritonitis by polymyxin-B haemoperfusion
por: Coudroy, R, et al.
Publicado: (2015)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by Acinetobacter baumanii and Pseudomonas aeruginosa
por: Macedo, SK, et al.
Publicado: (2011)

Sulfonated immunoglobulin improves cardiopulmonary functions by promoting IGF-I production in ARDS patients with severe sepsis
por: Deguchi, Y, et al.
Publicado: (2011)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
por: Khan, Tina, et al.
Publicado: (2015)

Anti-endotoxin Properties of Polymyxin B-immobilized Fibers
por: Tani, Tohru, et al.
Publicado: (2019)

Newly developed plasma soluble E-selectin rapid assay predicts prevalence of acute respiratory distress syndrome in critically ill patients
por: Okajima, K, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6b0alfl4hkqus3of9rbntc84ro